The Federal Trade Commission reached a settlement with Cigna’s Express Scripts in a case over alleged inflation of insulin prices, according to a Feb. 4 agency news release. With the move, the FTC ...
The Federal Trade Commission said it has reached a settlement with Express Scripts, resolving an earlier lawsuit that alleged the pharmacy benefit manager artificially inflated insulin drug prices.
The FTC first sued Express Scripts, CVS Caremark, and Optum in 2024, claiming anticompetitive and unfair rebating practices surrounding insulin. “Caremark, [Express Scripts], and Optum—as medication ...
Pharmacy benefit managers, which set how drugs are covered by health insurance, have faced a decade of scrutiny from regulators and lawmakers over pricing.
Connecticut cities accuse PBMs and drugmakers of an insulin pricing scheme, filing federal lawsuits seeking damages and injunctions.
A bipartisan federal law and FTC action aim to rein in pharmacy benefit managers, increase transparency and curb pricing incentives critics say drive up prescription drug costs.
Senators Hawley and Warren want to break up vertically integrated healthcare conglomerates. History shows, however, how hard a task this will be to accomplish.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results